Position Statement on Use of Pathogen‐Reduced Cryoprecipitate in Settings Where Commercial Clotting Factor Concentrates are Unavailable or Unaffordable
9 July 2009
| Position paper
WHO Team
Medicines and Health Products, Policies and Standards (HPS)
Number of pages
5